A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of TD-5108 for the Treatment of Chronic Constipation.
Latest Information Update: 08 Nov 2021
At a glance
- Drugs Velusetrag (Primary)
- Indications Constipation
- Focus Proof of concept; Therapeutic Use
- Acronyms ACCORD
- Sponsors Theravance Biopharma
Most Recent Events
- 04 Sep 2010 New trial record